CytomX Therapeutics, Inc. CTMX
NASDAQ · United States · Health Technology
$2.67-0.05 (-1.84%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.09 | -0.08 | -16.8% | $1.42M | -88.6% | +3.3%$3.35→$3.46 |
| Q1 2026 | 2026-05-07 | -0.10 | -0.14 | +28.6% | — | — | -3.6%$4.13→$3.98 |
| Q4 2025 | 2026-03-16 | -0.22 | -0.09 | -144.4% | — | — | +16.5%$4.68→$5.45 |
| Q3 2025 | 2025-11-06 | -0.09 | -0.04 | -125.0% | — | — | -14.0%$4.21→$3.62 |
| Q1 2025 | 2025-05-12 | 0.27 | 0.13 | +107.7% | — | — | — |
| Q4 2024 | 2025-03-06 | 0.23 | -0.11 | +309.1% | — | — | — |
| Q4 2023 | 2024-03-11 | 0.01 | -0.03 | +133.3% | — | — | — |
| Q3 2023 | 2023-11-07 | 0.04 | -0.21 | +119.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.